REZOLUTE, INC. Accounts Payable
REZOLUTE, INC. (RZLT) had Accounts Payable of $5.03 million as of 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-09-24
- 2026-06-30: Accounts Payable, Current $5.03M.
- 2026-03-31: Accounts Payable, Current $3.19M.
- 2025-12-31: Accounts Payable, Current $3.78M.
- 2025-09-30: Accounts Payable, Current $3.26M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.03M 10-K · filed 2026-09-24 | |
| 2026-03-31 | $3.19M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $3.78M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $3.26M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $5.81M 10-K · filed 2026-09-24 | |
| 2025-03-31 | $6.50M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $3.15M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $2.18M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $4.90M 10-K · filed 2025-09-17 | |
| 2024-03-31 | $3.50M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $3.59M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $2.43M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $3.27M 10-K · filed 2024-09-19 | |
| 2023-03-31 | $2.95M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.84M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $1.11M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.13M 10-K · filed 2023-09-14 | |
| 2022-03-31 | $1.56M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $4.35M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $1.59M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.03M 10-K · filed 2022-09-15 | |
| 2021-03-31 | $811.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $612.00K 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $797.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $893.00K 10-K · filed 2021-09-15 | |
| 2020-03-31 | $1.26M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.25M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $1.32M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $563.00K 10-K · filed 2020-10-13 | |
| 2014-06-30 | $460.31K 10-K · filed 2014-09-30 | |
| 2014-03-31 | $645.70K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $477.50K 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $408.88K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $188.35K 10-K · filed 2014-09-30 | |
| 2013-03-31 | $252.44K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $8.60K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $15.64K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $107.02K 10-K · filed 2013-09-11 | $10.55K 10-K/A · filed 2012-11-09 |
| 2012-03-31 | $8.85K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $186.76K 10-K · filed 2013-09-11 | $5.87K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $5.50K 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | $11.66K 10-K/A · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |